SG Americas Securities
ELAN icon

SG Americas Securities’s Elanco Animal Health ELAN Stock Holding History

SG Americas Securities’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-23,000
Closed -$43K – 3167
2019
Q1 		$43K Buy
+23,000
New +$708K ﹤0.01% 3219

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

SG Americas Securities's ELAN Position: Q1 2026 in Review

SG Americas Securities reduced its Elanco Animal Health (ELAN) stake by 65% in Q1 2026, selling an estimated $1.52M and leaving 33,298 shares worth $797K. The position accounts for ﹤0.01% of the portfolio, ranked #1912.

SG Americas Securities first reported a position in ELAN in Q1 2019 and has held it in 23 quarters since. The position peaked at $3.41M in Q4 2019. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • SG Americas Securities held 33,298 shares of Elanco Animal Health worth $797K as of Q1 2026.
  • SG Americas Securities sold 62,227 Elanco Animal Health shares in Q1 2026, an estimated $1.52M.
  • Elanco Animal Health made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #1912 holding.
  • SG Americas Securities first reported a position in Elanco Animal Health in Q1 2019 and has held it in 23 quarters since.
  • SG Americas Securities's Elanco Animal Health position peaked at $3.41M in Q4 2019.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.